Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 15,090.00p on 16-02-2026 at 16:25:49
Change -28.00p -0.19%
Buy 15,092.00p
Sell 15,090.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 42.00 at 15,090.00p
Day's Volume: 569,248
Last Close: 15,118.00p
Open: 15,186.00p
ISIN: GB0009895292
Day's Range 14,944.00p - 15,188.00p
52wk Range: 9,574.00p - 15,188.00p
Market Capitalisation: £233.94b
VWAP: 15,058.21708p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 42 15,090.00p Automatic Execution
 16:25:49 - 16-Feb-26
Buy* 64 15,090.00p Automatic Execution
 16:25:49 - 16-Feb-26
Buy* 31 15,090.00p Automatic Execution
 16:25:40 - 16-Feb-26
Buy* 108 15,090.00p SI Trade
 16:25:38 - 16-Feb-26
Sell* 61 15,088.00p Automatic Execution
 16:25:38 - 16-Feb-26
Buy* 101 15,090.00p Automatic Execution
 16:25:38 - 16-Feb-26
Buy* 33 15,090.00p Automatic Execution
 16:25:38 - 16-Feb-26
Buy* 64 15,090.00p Automatic Execution
 16:25:38 - 16-Feb-26
Buy* 25 15,086.00p Automatic Execution
 16:25:27 - 16-Feb-26
Buy* 4 15,086.00p Automatic Execution
 16:25:27 - 16-Feb-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
16th Feb 2026 (Mon) 15,186.00 15,188.00 14,944.00 15,118.00 569,248
13th Feb 2026 (Fri) 14,986.00 15,186.00 14,816.00 15,118.00 6,247,443
12th Feb 2026 (Thu) 14,918.00 15,028.00 14,782.00 14,906.00 1,393,202
11th Feb 2026 (Wed) 14,118.00 14,818.00 14,074.00 14,818.00 3,601,531
10th Feb 2026 (Tue) 13,952.00 14,314.00 13,748.00 14,164.00 3,682,197
9th Feb 2026 (Mon) 14,184.00 14,250.00 13,858.00 13,888.00 4,085,396
6th Feb 2026 (Fri) 13,884.00 14,112.00 13,846.00 14,104.00 3,108,416
5th Feb 2026 (Thu) 13,790.00 14,068.00 13,696.00 13,980.00 1,437,883
4th Feb 2026 (Wed) 13,472.00 13,926.00 13,444.00 13,796.00 2,067,316
3rd Feb 2026 (Tue) 13,808.00 13,942.00 13,636.00 13,816.00 1,443,630
2nd Feb 2026 (Mon) 13,532.00 14,060.00 13,500.00 14,040.00 1,342,224
30th Jan 2026 (Fri) 13,328.00 13,600.00 13,326.00 13,600.00 1,640,379
29th Jan 2026 (Thu) 13,406.00 13,564.00 13,402.00 13,460.00 2,707,843
28th Jan 2026 (Wed) 13,818.00 13,822.00 13,478.00 13,508.00 2,526,744
27th Jan 2026 (Tue) 13,800.00 13,986.00 13,736.00 13,880.00 1,444,248
26th Jan 2026 (Mon) 13,642.00 13,770.00 13,560.00 13,752.00 1,555,763
23rd Jan 2026 (Fri) 13,702.00 13,704.00 13,512.00 13,580.00 1,574,503
22nd Jan 2026 (Thu) 13,540.00 13,604.00 13,428.00 13,560.00 2,673,261
21st Jan 2026 (Wed) 13,482.00 13,496.00 13,292.00 13,338.00 2,379,951
20th Jan 2026 (Tue) 13,786.00 13,786.00 13,268.00 13,520.00 3,045,271
19th Jan 2026 (Mon) 13,994.00 14,188.00 13,890.00 13,890.00 1,536,668
16th Jan 2026 (Fri) 14,020.00 14,154.00 13,972.00 14,052.00 3,712,321
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
10th Feb 2026 7:00 am RNS Final Results
3rd Feb 2026 7:00 am RNS Update on Saphnelo subcutaneous administration
2nd Feb 2026 3:00 pm RNS Total Voting Rights
2nd Feb 2026 7:05 am RNS Imfinzi recommended in EU for early gastric cancer
2nd Feb 2026 7:00 am RNS AstraZeneca begins trading on NYSE
30th Jan 2026 7:00 am RNS AstraZeneca agrees obesity and T2D deal with CSPC
29th Jan 2026 9:51 am RNS AstraZeneca invests $15bn in China through 2030
20th Jan 2026 7:00 am RNS AstraZeneca to complete direct listing on NYSE
8th Jan 2026 7:00 am RNS AZN new Head of Investor Relations Joris Silon
2nd Jan 2026 3:00 pm RNS Total Voting Rights
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

LONDON BROKER RATINGS: RBC cuts Schroders, LBBW says 'hold' Unilever

16th Feb 2026 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON MARKET MIDDAY: Stocks edge lower ahead of US CPI data

13th Feb 2026 12:12

(Alliance News) - Stock prices in London were modestly lower at midday on Friday, with sentiment cautious ahead of US inflation data and the Munich Security Conference in focus. Read More

LONDON BROKER RATINGS: Bernstein, Barclays and Deutsche lower Relx

13th Feb 2026 09:51

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

AstraZeneca rises on positive trial results for asthma therapy

13th Feb 2026 09:16

(Alliance News) - Astrazeneca on Friday hailed positive results from a phase-three trial of its asthma treatment breztri aerosphere. Read More

LONDON BRIEFING: NatWest results ahead of forecasts, ups dividend 51%

13th Feb 2026 07:58

(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data for Breztri in asthma, as UK retail footfall improves from a weak Christmas period but remains below last year's levels. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,466.65
Change20.30

Login to your account

Forgot Password?

Not Registered